E
Beta Bionics, Inc. BBNX
$10.80 -$0.16-1.46% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Total Cash And Short-Term Investments 7.06% --
Total Receivables 169.69% --
Inventory 969.88% --
Prepaid Expenses 228.41% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets 281.82% --
Total Current Assets 28.28% --

Total Current Assets 28.28% --
Net Property, Plant & Equipment 84.27% --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 2,298.64% --
Total Assets 35.99% --

Total Accounts Payable 144.60% --
Total Accrued Expenses 88.46% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 24.92% --
Total Finance Division Other Current Liabilities 201.05% --
Total Other Current Liabilities 201.05% --
Total Current Liabilities 99.42% --

Total Current Liabilities 99.42% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 90.93% --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 23.61% --
Total Liabilities 43.16% --

Common Stock & APIC 94.20% --
Retained Earnings -29.20% --
Treasury Stock & Other -52.55% --
Total Common Equity -20.80% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 22.80% --
Preferred Stock, Others -- --
Total Preferred Equity 22.80% --

Total Common Equity -20.80% --
Total Preferred Equity 22.80% --
Total Minority Interest -- --
Total Equity 29.70% --